CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 772 of 1
Non-Antibody Products
Page 772 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| ML-161 | An allosteric, reversible inhibitor of PAR1 on platelets, preventing surfa… | 25 mg | 15179-25 | More Info |
| ML-161 | An allosteric, reversible inhibitor of PAR1 on platelets, preventing surfa… | 5 mg | 15179-5 | More Info |
| ML-162 | A GPX4 inhibitor; decreases GPX4 levels in MDA-MB-231 cells; decreases via… | 1 mg | 20455-1 | More Info |
| ML-162 | A GPX4 inhibitor; decreases GPX4 levels in MDA-MB-231 cells; decreases via… | 10 mg | 20455-10 | More Info |
| ML-162 | A GPX4 inhibitor; decreases GPX4 levels in MDA-MB-231 cells; decreases via… | 25 mg | 20455-25 | More Info |
| ML-162 | A GPX4 inhibitor; decreases GPX4 levels in MDA-MB-231 cells; decreases via… | 5 mg | 20455-5 | More Info |
| ML-167 | A selective, ATP-competitive inhibitor of Clk4 (IC50 = 136 nM) | 1 mg | 18098-1 | More Info |
| ML-167 | A selective, ATP-competitive inhibitor of Clk4 (IC50 = 136 nM) | 10 mg | 18098-10 | More Info |
| ML-167 | A selective, ATP-competitive inhibitor of Clk4 (IC50 = 136 nM) | 5 mg | 18098-5 | More Info |
| ML-178 | A selective S1P4 agonist (EC50 = 46.3 nM) | 1 mg | 18527-1 | More Info |
| ML-178 | A selective S1P4 agonist (EC50 = 46.3 nM) | 10 mg | 18527-10 | More Info |
| ML-178 | A selective S1P4 agonist (EC50 = 46.3 nM) | 25 mg | 18527-25 | More Info |
| ML-178 | A selective S1P4 agonist (EC50 = 46.3 nM) | 5 mg | 18527-5 | More Info |
| ML-179 | A potent inverse agonist of LRH-1 (IC50 = 320 nM) with maximum efficacy of… | 1 mg | 15180-1 | More Info |
| ML-179 | A potent inverse agonist of LRH-1 (IC50 = 320 nM) with maximum efficacy of… | 10 mg | 15180-10 | More Info |
| ML-179 | A potent inverse agonist of LRH-1 (IC50 = 320 nM) with maximum efficacy of… | 25 mg | 15180-25 | More Info |
| ML-179 | A potent inverse agonist of LRH-1 (IC50 = 320 nM) with maximum efficacy of… | 5 mg | 15180-5 | More Info |
| ML-18 | A BB3 receptor antagonist; inhibits [125I]BA1 binding to NCI-H1299 lung ca… | 1 mg | 27319-1 | More Info |
| ML-18 | A BB3 receptor antagonist; inhibits [125I]BA1 binding to NCI-H1299 lung ca… | 10 mg | 27319-10 | More Info |
| ML-18 | A BB3 receptor antagonist; inhibits [125I]BA1 binding to NCI-H1299 lung ca… | 5 mg | 27319-5 | More Info |
| ML-18 | A BB3 receptor antagonist; inhibits [125I]BA1 binding to NCI-H1299 lung ca… | 500 µg | 27319-500 | More Info |
| ML-180 | An inverse agonist of LRH-1 (IC50 = 3.7 µM) with maximum efficacy of… | 1 mg | 15181-1 | More Info |
| ML-180 | An inverse agonist of LRH-1 (IC50 = 3.7 µM) with maximum efficacy of… | 10 mg | 15181-10 | More Info |
| ML-180 | An inverse agonist of LRH-1 (IC50 = 3.7 µM) with maximum efficacy of… | 25 mg | 15181-25 | More Info |
| ML-180 | An inverse agonist of LRH-1 (IC50 = 3.7 µM) with maximum efficacy of… | 5 mg | 15181-5 | More Info |
| ML-184 | A potent synthetic agonist of GPR55 (EC50 = 0.26 µM); does not act a… | 1 mg | 17641-1 | More Info |
| ML-184 | A potent synthetic agonist of GPR55 (EC50 = 0.26 µM); does not act a… | 10 mg | 17641-10 | More Info |
| ML-184 | A potent synthetic agonist of GPR55 (EC50 = 0.26 µM); does not act a… | 25 mg | 17641-25 | More Info |
| ML-184 | A potent synthetic agonist of GPR55 (EC50 = 0.26 µM); does not act a… | 5 mg | 17641-5 | More Info |
| ML-188 | An inhibitor of SARS-CoV Mpro (IC50 = 1.5 µM) | 1 mg | 37346-1 | More Info |
| ML-188 | An inhibitor of SARS-CoV Mpro (IC50 = 1.5 µM) | 10 mg | 37346-10 | More Info |
| ML-188 | An inhibitor of SARS-CoV Mpro (IC50 = 1.5 µM) | 25 mg | 37346-25 | More Info |
| ML-188 | An inhibitor of SARS-CoV Mpro (IC50 = 1.5 µM) | 5 mg | 37346-5 | More Info |
| ML-191 | An antagonist of GPR55; inhibits LPI-induced GPR55 signaling (EC50 = 1.076… | 1 mg | 15182-1 | More Info |
| ML-191 | An antagonist of GPR55; inhibits LPI-induced GPR55 signaling (EC50 = 1.076… | 10 mg | 15182-10 | More Info |
| ML-191 | An antagonist of GPR55; inhibits LPI-induced GPR55 signaling (EC50 = 1.076… | 25 mg | 15182-25 | More Info |
| ML-191 | An antagonist of GPR55; inhibits LPI-induced GPR55 signaling (EC50 = 1.076… | 5 mg | 15182-5 | More Info |
| ML-192 | A selective GPR55 antagonist (IC50 = 702 nM); selective for GPR55 over CB1… | 1 mg | 15183-1 | More Info |
| ML-192 | A selective GPR55 antagonist (IC50 = 702 nM); selective for GPR55 over CB1… | 10 mg | 15183-10 | More Info |
| ML-192 | A selective GPR55 antagonist (IC50 = 702 nM); selective for GPR55 over CB1… | 5 mg | 15183-5 | More Info |
| ML-193 | A potent, selective antagonist of the GPR55 receptor (IC50 = 221 nM) | 1 mg | 15184-1 | More Info |
| ML-193 | A potent, selective antagonist of the GPR55 receptor (IC50 = 221 nM) | 10 mg | 15184-10 | More Info |
| ML-193 | A potent, selective antagonist of the GPR55 receptor (IC50 = 221 nM) | 25 mg | 15184-25 | More Info |
| ML-193 | A potent, selective antagonist of the GPR55 receptor (IC50 = 221 nM) | 5 mg | 15184-5 | More Info |
| ML-198 | A chemical chaperone of glucocerebrosidase; activates hydrolysis of 4-MUG… | 1 mg | 37755-1 | More Info |
| ML-198 | A chemical chaperone of glucocerebrosidase; activates hydrolysis of 4-MUG… | 10 mg | 37755-10 | More Info |
| ML-198 | A chemical chaperone of glucocerebrosidase; activates hydrolysis of 4-MUG… | 5 mg | 37755-5 | More Info |
| ML-202 | A PKM2 activator; induces PMK2 activation in a cell-free assay (AC50 = 73… | 1 mg | 37326-1 | More Info |
| ML-202 | A PKM2 activator; induces PMK2 activation in a cell-free assay (AC50 = 73… | 10 mg | 37326-10 | More Info |
| ML-202 | A PKM2 activator; induces PMK2 activation in a cell-free assay (AC50 = 73… | 25 mg | 37326-25 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile